Franklin Resources
VNDA icon

Franklin Resources’s Vanda Pharmaceuticals VNDA Stock Holding History

Franklin Resources’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Buy
91,170
+840
+0.9% +$5.49K ﹤0.01% 2533
2026
Q1 		$624K Buy
+90,330
New +$697K ﹤0.01% 2386
2025
Q2 		– Sell
-38,926
Closed -$179K – 3138
2025
Q1 		$179K Buy
38,926
+19,146
+97% +$89.2K ﹤0.01% 2718
2024
Q4 		$94.7K Sell
19,780
-35,446
-64% -$170K ﹤0.01% 2757
2024
Q3 		$266K Buy
55,226
+4,449
+9% +$23.9K ﹤0.01% 2535
2024
Q2 		$287K Buy
50,777
+31,845
+168% +$164K ﹤0.01% 2445
2024
Q1 		$77.8K Buy
18,932
+791
+4% +$3.17K ﹤0.01% 2735
2023
Q4 		$76.6K Sell
18,141
-42,751
-70% -$172K ﹤0.01% 2496
2023
Q3 		$263K Sell
60,892
-137,431
-69% -$764K ﹤0.01% 2208
2023
Q2 		$1.31M Buy
198,323
+35,572
+22% +$228K ﹤0.01% 1557
2023
Q1 		$1.11M Buy
162,751
+840
+0.5% +$5.91K ﹤0.01% 1479
2022
Q4 		$1.2M Buy
161,911
+519
+0.3% +$5.05K ﹤0.01% 1479
2022
Q3 		$1.59M Buy
161,392
+80,777
+100% +$853K ﹤0.01% 1410
2022
Q2 		$880K Buy
80,615
+48,864
+154% +$506K ﹤0.01% 1565
2022
Q1 		$359K Hold
31,751
– – ﹤0.01% 1947
2021
Q4 		$498K Sell
31,751
-146
-0.5% -$2.54K ﹤0.01% 1907
2021
Q3 		$546K Buy
+31,897
New +$559K ﹤0.01% 1852

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's VNDA Position: Q2 2026 in Review

Franklin Resources increased its Vanda Pharmaceuticals (VNDA) stake by 0.93% in Q2 2026, buying an estimated $5.49K and bringing the position to 91,170 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Franklin Resources first reported a position in VNDA in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.59M in Q3 2022. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Franklin Resources held 91,170 shares of Vanda Pharmaceuticals worth $558K as of Q2 2026.
  • Franklin Resources bought 840 Vanda Pharmaceuticals shares in Q2 2026, an estimated $5.49K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2533 holding.
  • Franklin Resources first reported a position in Vanda Pharmaceuticals in Q3 2021 and has held it in 17 quarters since.
  • Franklin Resources's Vanda Pharmaceuticals position peaked at $1.59M in Q3 2022.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.